{"id":1896,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2018-09-27","marketCap":1859.86,"name":"Arvinas Inc","phone":"12035351456","outstanding":55.03,"symbol":"ARVN","website":"https://www.arvinas.com/","industry":"Pharmaceuticals"},"price":33.155,"year":2023,"month":12,"day":14,"weekday":"Thursday","title":"Ownership Structure of Arvinas Inc","date":"2023-12-14","url":"/posts/2023/12/14/ARVN","content":[{"section":"Major Shareholders","text":"The major shareholders of Arvinas Inc include institutional investors and insiders. As of the latest available data, the top institutional shareholders are BlackRock, Vanguard Group, and Fidelity Management \u0026 Research Company. These institutions hold a significant percentage of the total shares outstanding."},{"section":"Institutional Investors","text":"BlackRock is the largest institutional investor in Arvinas Inc, owning approximately 15% of the total shares outstanding. The Vanguard Group holds around 10% of the shares, while Fidelity Management \u0026 Research Company owns about 8%. Other notable institutional investors include State Street Corporation, Wellington Management Company, and T. Rowe Price Associates."},{"section":"Insider Ownership","text":"Insiders, including directors and executives of Arvinas Inc, also hold a notable percentage of the company's shares. The insider ownership is around 5%, indicating that the management team has a significant stake in the company's success. This aligns their interests with those of the shareholders."},{"section":"Summary","text":"Arvinas Inc has a diversified ownership structure with significant institutional investor participation. The major shareholders are BlackRock, Vanguard Group, and Fidelity Management \u0026 Research Company. The management team and other insiders hold a notable stake in the company, demonstrating their commitment to its success."}],"tags":["CrossOver55","Long","Pharmaceuticals"],"news":[{"category":"company","date":1702036800,"headline":"Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session","id":124392149,"image":"","symbol":"ARVN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3248096526"},{"category":"company","date":1702028580,"headline":"Torrid Reports Upbeat Results, Joins MBIA, Virco Mfg. And Other Big Stocks Moving Higher On Friday","id":124388769,"image":"","symbol":"ARVN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3247925808"},{"category":"company","date":1702025580,"headline":"Arvinas files to sell 16.39M shares of common stock for holders","id":124390959,"image":"","symbol":"ARVN","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3247866502"},{"category":"company","date":1701927660,"headline":"Analysts Are Bullish on Top Healthcare Stocks: Veeva Systems (VEEV), Wuxi Biologics (Cayman) (WXIBF)","id":124367770,"image":"","symbol":"ARVN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245760044"},{"category":"company","date":1701922320,"headline":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arvinas Holding Company (ARVN), Abbott Labs (ABT) and Owens \u0026 Minor (OMI)","id":124363380,"image":"","symbol":"ARVN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245684349"},{"category":"company","date":1701914580,"headline":"Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Regeneron (REGN) and Arvinas Holding Company (ARVN)","id":124362059,"image":"","symbol":"ARVN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245587882"},{"category":"company","date":1701879480,"headline":"Pfizer (PFE), Arvinas Post Upbeat Data From Breast Cancer Study","id":124340216,"image":"https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","symbol":"ARVN","publisher":"Yahoo","summary":"Interim data from an early-stage study shows that treatment with Pfizer (PFE)/Arvinas' (ARVN) breast cancer combination therapy demonstrates encouraging clinical activity in heavily pre-treated patients.","url":"https://finance.yahoo.com/news/pfizer-pfe-arvinas-post-upbeat-161800950.html"},{"category":"company","date":1701866880,"headline":"Arvinas stock jumps 30% amid positive data for breast cancer drug","id":124369896,"image":"","symbol":"ARVN","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244426204"},{"category":"company","date":1701863040,"headline":"ALT, SYRS and PHIO among mid-day movers","id":124336953,"image":"","symbol":"ARVN","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244330252"},{"category":"company","date":1701862380,"headline":"12 Health Care Stocks Moving In Wednesday's Intraday Session","id":124338947,"image":"","symbol":"ARVN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244316922"},{"category":"company","date":1701859560,"headline":"Buy Rating Affirmed for Arvinas Holding Company on Strong Clinical Data and Therapeutic Potential","id":124369902,"image":"","symbol":"ARVN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244249884"},{"category":"company","date":1701857220,"headline":"Arvinas upgraded to Buy at Jefferies after vepdegestrant combo data reported","id":124333197,"image":"","symbol":"ARVN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244194298"},{"category":"company","date":1701856680,"headline":"Jefferies gets more bullish on Arvinas, upgrades shares","id":124333198,"image":"","symbol":"ARVN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244180955"},{"category":"company","date":1701856380,"headline":"THOR Industries Reports Upbeat Earnings, Joins Dave \u0026 Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday","id":124333015,"image":"","symbol":"ARVN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244174973"},{"category":"company","date":1701854027,"headline":"Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib and Plans to Expand Vepdegestrant Development Program","id":124330567,"image":"","symbol":"ARVN","publisher":"Finnhub","summary":"NEW HAVEN - Arvinas, Inc. and Pfizer Inc. today announced clinical data for vepdegestrant , a novel oral PROteolysis TArgeting Chimera estrogen receptor degrader, in combination with palbociclib...","url":"https://finnhub.io/api/news?id=203226eff00ceb4561270ce0627dd685a3b9ff76bec6d08dc666172bc36cd543"},{"category":"company","date":1701849120,"headline":"Arvinas, Pfizer Plan To Broaden Development Of Breast Cancer Candidate","id":124332577,"image":"","symbol":"ARVN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244015125"},{"category":"company","date":1701848040,"headline":"Arvinas price target raised to $33 from $24 at Wedbush","id":124333201,"image":"","symbol":"ARVN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3243993224"},{"category":"company","date":1701834720,"headline":"Arvinas to Host Conference Call and Webcast to Discuss Vepdegestrant (ARV-471) Data Presented at 2023 San Antonio Breast Cancer Symposium and Plans to Expand Vepdegestrant Development Program","id":124327511,"image":"https://media.zenfs.com/en/globenewswire.com/92323019a5a4213cf6ded7f6af366081","symbol":"ARVN","publisher":"Yahoo","summary":"NEW HAVEN, Conn., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that a conference call and webcast will be held with executives from Arvinas and Pfizer Inc. (NYSE: PFE) to discuss vepdegestrant (ARV-471) data presented at the 2023 San Antonio Breast Cancer Symposium (SABCS) as well as plans to expand the vepdegestrant development program. Investor Call \u0026 W","url":"https://finance.yahoo.com/news/arvinas-host-conference-call-webcast-035200504.html"},{"category":"company","date":1701827220,"headline":"Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session","id":124339785,"image":"","symbol":"ARVN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244515708"},{"category":"company","date":1701824760,"headline":"Jefferies upgrades Arvinas to buy in wake of positive ARV-471 data","id":124369906,"image":"","symbol":"ARVN","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244452468"},{"category":"company","date":1701801180,"headline":"Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) and Plans to Expand Vepdegestrant Development Program","id":124320524,"image":"https://media.zenfs.com/en/globenewswire.com/92323019a5a4213cf6ded7f6af366081","symbol":"ARVN","publisher":"Yahoo","summary":"– Overall response rate of 42% and median progression-free survival of 11.1 months in heavily pre-treated patients (after 11 months median follow-up time and based on 48% of events) demonstrates the potential of vepdegestrant in combination with palbociclib (IBRANCE®) – – Tolerability generally consistent with the profile of palbociclib and what has been observed in other clinical trials of vepdegestrant– – Pending additional data and agreement with regulatory authorities, Arvinas and Pfizer pla","url":"https://finance.yahoo.com/news/arvinas-pfizer-announce-interim-data-183300772.html"},{"category":"company","date":1701780120,"headline":"Arvinas, Pfizer report interim data from trial of vepdegestrant with palbociclib","id":124321208,"image":"","symbol":"ARVN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3242551258"},{"category":"company","date":1701442511,"headline":"Does Arvinas, Inc. (ARVN) Have the Potential to Rally 145.52% as Wall Street Analysts Expect?","id":124240428,"image":"https://media.zenfs.com/en/zacks.com/1154d43aaeb65735a640003549116295","symbol":"ARVN","publisher":"Yahoo","summary":"The average of price targets set by Wall Street analysts indicates a potential upside of 145.5% in Arvinas, Inc. (ARVN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.","url":"https://finance.yahoo.com/news/does-arvinas-inc-arvn-potential-145511974.html"},{"category":"company","date":1701325860,"headline":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Treace Medical Concepts (TMCI), Arvinas Holding Company (ARVN) and Cooper Co (COO)","id":124200978,"image":"","symbol":"ARVN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3234913569"}]}